Eyebright Medical Technology (Beijing) Co., Ltd.
SSE:688050.SS
74.16 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 357.183 | 334.755 | 385.019 | 370.48 | 308.965 | 279.369 | 261.25 | 217.059 | 189.79 | 138.181 | 168.336 | 141.686 | 131.293 | 108.173 | 118.61 | 121.878 | 84.409 | 91.53 | 77.939 | 77.366 | 26.213 | 55.259 | 45.246 | 51.614 | 43.079 | 37.904 |
| Cost of Revenue
| 126.439 | 127.864 | 140.431 | 132.06 | 88.127 | 115.468 | 55.013 | 36.58 | 31.969 | 23.956 | 24.088 | 20.768 | 19.539 | 16.004 | 18.624 | 19.134 | 14.279 | 16.32 | 12.574 | 11.144 | 3.898 | 27.941 | 6.801 | 7.021 | 6.11 | 23.655 |
| Gross Profit
| 230.744 | 206.891 | 244.589 | 238.42 | 220.838 | 163.901 | 206.237 | 180.478 | 157.821 | 114.226 | 144.248 | 120.918 | 111.754 | 92.169 | 99.986 | 102.744 | 70.131 | 75.211 | 65.365 | 66.223 | 22.315 | 27.318 | 38.445 | 44.593 | 36.969 | 14.249 |
| Gross Profit Ratio
| 0.646 | 0.618 | 0.635 | 0.644 | 0.715 | 0.587 | 0.789 | 0.831 | 0.832 | 0.827 | 0.857 | 0.853 | 0.851 | 0.852 | 0.843 | 0.843 | 0.831 | 0.822 | 0.839 | 0.856 | 0.851 | 0.494 | 0.85 | 0.864 | 0.858 | 0.376 |
| Reseach & Development Expenses
| 26.197 | 29.544 | 30.461 | 22.377 | 21.009 | 25.668 | 23.077 | 21.316 | 20.281 | 22.25 | 16.832 | 14.265 | 12.616 | 15.422 | 15.198 | 10.449 | 10.846 | 11.39 | 7.104 | 6.305 | 5.193 | 7.09 | 5.361 | 4.997 | 4.229 | 0 |
| General & Administrative Expenses
| 40.2 | -63.571 | 102.309 | -18.671 | 36.212 | 39.555 | 62.202 | -8.637 | 21.861 | -25.078 | 36.838 | -2.872 | 13.441 | -18.12 | 28.118 | -2.424 | 10.555 | -15.551 | 10.846 | 1.395 | 1.777 | 9.074 | 8.334 | 4.02 | 1.321 | 0 |
| Selling & Marketing Expenses
| 61.398 | -43.419 | 80.614 | 59.537 | 47.527 | 56.473 | 51.706 | 47.39 | 27.837 | 41.491 | 28.5 | 20.209 | 17.824 | 29.216 | 25.066 | 22.425 | 13.215 | 24.738 | 14.31 | 10.288 | 7.918 | 16.163 | 14.181 | 12.262 | 7.808 | 0 |
| SG&A
| 101.598 | -106.99 | 89.676 | 97.377 | 86.513 | 92.401 | 113.909 | 38.754 | 49.698 | 16.412 | 65.338 | 17.337 | 31.265 | 11.096 | 53.184 | 20.001 | 23.771 | 9.187 | 25.156 | 11.682 | 9.695 | 25.831 | 22.515 | 16.281 | 9.129 | 0 |
| Other Expenses
| 1.948 | 214.394 | 0.354 | 0.059 | 0.121 | 1.339 | 0.051 | -0.216 | 2.488 | 44.935 | -16.769 | 19.115 | -0.636 | -1.223 | 4.011 | -0.026 | 0.015 | 0.028 | -0.014 | -0.038 | -0.193 | -9.95 | -0.006 | 0.036 | -0.07 | -8.822 |
| Operating Expenses
| 129.744 | 136.947 | 119.782 | 119.695 | 107.522 | 116.73 | 107.423 | 89.883 | 72.467 | 83.597 | 65.401 | 50.717 | 43.245 | 60.184 | 56.348 | 45.3 | 35.593 | 48.705 | 32.485 | 23.991 | 20.364 | -9.95 | 28.35 | 25.313 | 16.814 | -8.822 |
| Operating Income
| 101 | 69.944 | 124.806 | 118.725 | 113.317 | 47.171 | 98.303 | 92.208 | 86.724 | 29.358 | 83.359 | 73.729 | 72.82 | 33.46 | 49.991 | 61.448 | 40.094 | 32.106 | 34.757 | 41.655 | 2.738 | 17.368 | 12.375 | 21.14 | 18.773 | 5.427 |
| Operating Income Ratio
| 0.283 | 0.209 | 0.324 | 0.32 | 0.367 | 0.169 | 0.376 | 0.425 | 0.457 | 0.212 | 0.495 | 0.52 | 0.555 | 0.309 | 0.421 | 0.504 | 0.475 | 0.351 | 0.446 | 0.538 | 0.104 | 0.314 | 0.273 | 0.41 | 0.436 | 0.143 |
| Total Other Income Expenses Net
| 0.069 | -0.67 | 0.371 | 2.692 | 0.089 | 3.272 | 0.051 | -0.216 | 0.094 | 2.925 | 2.606 | -0.794 | 0.132 | -1.223 | 4.011 | -0.026 | 0.015 | 0.028 | 0.092 | -0.038 | -0.193 | 0.04 | -0.006 | 0.036 | -0.07 | 0.007 |
| Income Before Tax
| 101.069 | 69.274 | 125.178 | 121.39 | 115.105 | 50.569 | 98.353 | 91.992 | 86.883 | 32.292 | 85.399 | 73.435 | 72.952 | 32.237 | 54.002 | 61.421 | 40.108 | 32.133 | 34.743 | 41.616 | 2.544 | 17.409 | 12.369 | 21.176 | 18.703 | 5.433 |
| Income Before Tax Ratio
| 0.283 | 0.207 | 0.325 | 0.328 | 0.373 | 0.181 | 0.376 | 0.424 | 0.458 | 0.234 | 0.507 | 0.518 | 0.556 | 0.298 | 0.455 | 0.504 | 0.475 | 0.351 | 0.446 | 0.538 | 0.097 | 0.315 | 0.273 | 0.41 | 0.434 | 0.143 |
| Income Tax Expense
| 11.256 | -13.763 | 20.401 | 20.707 | 16.672 | 8.047 | 13.332 | 9.795 | 10.446 | -0.551 | 11.605 | 9.814 | 15.979 | 3.216 | 6.173 | 6.651 | 3.974 | 4.186 | 3.352 | 7.875 | -0.494 | 91.832 | 0.615 | 1.856 | 1.541 | 73.647 |
| Net Income
| 92.558 | 70.811 | 109.552 | 105.137 | 102.903 | 52.008 | 88.789 | 84.784 | 78.398 | 33.7 | 75.831 | 64.473 | 58.69 | 31.032 | 48.864 | 55.442 | 36.007 | 27.898 | 31.121 | 34.123 | 3.415 | 17.643 | 12.348 | 19.533 | 17.161 | 3.698 |
| Net Income Ratio
| 0.259 | 0.212 | 0.285 | 0.284 | 0.333 | 0.186 | 0.34 | 0.391 | 0.413 | 0.244 | 0.45 | 0.455 | 0.447 | 0.287 | 0.412 | 0.455 | 0.427 | 0.305 | 0.399 | 0.441 | 0.13 | 0.319 | 0.273 | 0.378 | 0.398 | 0.098 |
| EPS
| 0.49 | 0.374 | 0.58 | 0.56 | 0.98 | 0.49 | 0.84 | 0.81 | 0.75 | 0.32 | 0.72 | 0.62 | 0.56 | 0.28 | 0.46 | 0.52 | 0.34 | 0.29 | 0.32 | 0.4 | 0.04 | 0.23 | 0.16 | 0.25 | 0.22 | 0.047 |
| EPS Diluted
| 0.49 | 0.374 | 0.58 | 0.56 | 0.98 | 0.49 | 0.84 | 0.81 | 0.75 | 0.32 | 0.72 | 0.62 | 0.56 | 0.28 | 0.46 | 0.52 | 0.34 | 0.29 | 0.32 | 0.4 | 0.04 | 0.23 | 0.16 | 0.25 | 0.22 | 0.047 |
| EBITDA
| 107.933 | 75.033 | 131.342 | 159.659 | 130.426 | 81.745 | 124.427 | 110.977 | 106.559 | 48.036 | 100.056 | 85.428 | 84.92 | 42.994 | 64.961 | 70.428 | 48.944 | 40.217 | 42.927 | 46.935 | 4.384 | 18.042 | 16.945 | 25.529 | 22.875 | -61.536 |
| EBITDA Ratio
| 0.302 | 0.224 | 0.341 | 0.431 | 0.422 | 0.293 | 0.476 | 0.511 | 0.561 | 0.348 | 0.594 | 0.603 | 0.647 | 0.397 | 0.548 | 0.578 | 0.58 | 0.439 | 0.551 | 0.607 | 0.167 | 0.327 | 0.375 | 0.495 | 0.531 | -1.623 |